35 studies found for:    " September 12, 2007":" October 12, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" September 12, 2007":" October 12, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed
Has Results
TMC278-TiDP6-C209: A Clinical Trial in Treatment Naive HIV-1 Patients Comparing TMC278 to Efavirenz in Combination With Tenofovir + Emtricitabine.
Conditions: HIV Infections;   HIV-1;   Human Immunodeficiency Virus Type 1
Interventions: Drug: TMC278;   Drug: efavirenz
2 Completed
Has Results
TMC278-TiDP6-C215: A Clinical Trial in Treatment Naive HIV-subjects Patients Comparing TMC278 to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors
Conditions: HIV Infections;   HIV-1
Interventions: Drug: TMC278;   Drug: efavirenz
3 Unknown  A Phase 1 Safety and Immunogenicity Study of the Epitope Based DNA Vaccine (EP HIV-1090) in HIV-1 Infected Individuals Receiving Antiretroviral Therapy (ART)
Condition: HIV Infections
Intervention: Biological: EP1090
4 Terminated HIV - Monotherapy in Switzerland (MOST-ch)
Condition: HIV Infections
Interventions: Drug: Lopinavir-Monotherapy;   Drug: HAART
5 Completed Phase I Safety and Immunogenicity Preventative Vaccine Trial Based on Recombinant Tat Protein
Condition: HIV Infections
Intervention: Biological: Biologically active recombinant Tat protein
6 Unknown  Pilot Study of the Impact of Adding Raltegravir (MK-0518) to Antiretroviral Therapy in Patients With Undetectable Plasma Virus
Condition: HIV Infections
Intervention: Drug: Raltegravir (MK-0518)
7 Completed
Has Results
HSV-2 Suppression to Reduce Maternal HIV-1 RNA Levels During Pregnancy and Breastfeeding
Conditions: HIV Infections;   Herpes Simplex
Interventions: Drug: valacyclovir;   Drug: placebo
8 Completed Effect of Soluble Fiber on Hypertriglyceridemia and Immune Profile in HIV-positive Individuals.
Conditions: Hypertriglyceridemia;   HIV Infections
Intervention: Dietary Supplement: soluble fiber® (partially hydrolyzed guar gum)
9 Completed A Study of Indinavir Plus Ritonavir Plus Two NRTIs vs. Nelfinavir Plus Two NRTIs in HIV Positive Patients
Condition: HIV Infections
Interventions: Drug: MK0639, indinavir sulfate / Duration of Treatment: 48 Weeks;   Drug: Comparator: nelfinavir mesylate / Duration of Treatment: 48 Weeks
10 Completed Pediatric Expanded Access Program-Oral Solution
Condition: HIV Infections
Intervention: Drug: MK0831
11 Completed Bioequivalency Study of Zidovudine Under Fed Conditions
Condition: HIV Infections
Intervention: Drug: Zidovudine
12 Completed Bioequivalency Study of Zidovudine Under Fasting Conditions
Condition: HIV Infections
Intervention: Drug: Zidovudine
13 Unknown  Diagnosis of Tuberculosis Infection in HIV Co-infected Children
Conditions: Latent Tuberculosis Infection;   Tuberculosis;   HIV Infections
Intervention:
14 Completed Double Protease Inhibitor to Darunavir Switch Study
Condition: HIV Infections
Intervention: Drug: Darunavir ritonavir
15 Unknown  Comparison of Epzicom and Truvada for the Initial Once Daily HIV Treatment
Condition: HIV Infections
Interventions: Drug: lamivudine, abacavir , ritonavir, atazanavir;   Drug: emtricitabine, tenofovir, ritonavir, atazanavir
16 Unknown  The Effect of Probiotics on the Immune Status, Diarrhea and Bacterial Vaginosis Cure Rate Among HIV Patients
Conditions: HIV Infections;   Diarrhea;   Bacterial Vaginosis
Interventions: Dietary Supplement: Lactobacillus rhamnosus GR-1 + Lactobacillus reuteri RC-14;   Dietary Supplement: Placebo;   Drug: Metronidazole
17 Completed
Has Results
Efficacy Study of Substitution of Darunavir/Ritonavir (DRV/r) for Dual-boosted Protease Inhibitors
Condition: HIV Infections
Interventions: Drug: Darunavir (DRV/r);   Drug: continue on current dual boosted PI
18 Completed The CogNaive Study: Assessing Changes in Neurocognitive Function in Treatment Naïve HIV-1 Positive Subjects
Condition: HIV Infections
Interventions: Drug: nevirapine;   Drug: atazanavir/ritonavir
19 Completed Blood Levels of Tenofovir Gel in HIV Uninfected Pregnant Women Planning Cesarean Delivery
Condition: HIV Infections
Intervention: Drug: Tenofovir 1% vaginal gel
20 Recruiting Characterization of Acute and Recent HIV-1 Infections in Zurich: a Long-Term Observational Study
Condition: HIV Infections
Interventions: Drug: lopinavir;   Drug: atazanavir;   Drug: efavirenz;   Drug: fosamprenavir;   Drug: darunavir;   Drug: tipranavir;   Drug: ritonavir;   Drug: nevirapine;   Drug: zidovudine;   Drug: lamivudine;   Drug: tenofovir;   Drug: emtricitabine;   Drug: abacavir

Previous Page Studies Shown (1-20) Next Page (21-35) Show next page of results
Indicates status has not been verified in more than two years